S. KATZENELBOGEN, M.D., F.A.C.P.; ALEXANDER SIMON, M.D.; ANNA R. COYNE, M.D.; CHARLES VIGUE, M.D.; ROBERT COHN, M.D.
This content is PDF only. Please click on the PDF icon to access.
The insulin treatment of schizophrenic patients is essentially a medical treatment. Yet, it challenges the medical man, as well as the physiopathologist and the pharmacologist with respect to the generally accepted notions on the dosage of insulin compatible with safety, and with respect to the tolerance of various individuals to excessive amounts of this drug. The challenge lies chiefly in the fact that the complications of the insulin treatment—the so-called hypoglycemic shock—much dreaded by the physiopathologist—has been raised by the psychopathologist to a therapeutic virtue. Furthermore, the new treatment, aside from its curative value, in using the old drug in
KATZENELBOGEN S, SIMON A, COYNE AR, et al. PHARMACOLOGICAL TREATMENT IN SCHIZOPHRENIC PATIENTS1. Ann Intern Med. 1940;14:393–405. doi: 10.7326/0003-4819-14-3-393
Download citation file:
Published: Ann Intern Med. 1940;14(3):393-405.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use